{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T09:40:24Z","timestamp":1657705224259},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T00:00:00Z","timestamp":1479081600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00399-016-0473-z","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T09:53:28Z","timestamp":1479117208000},"page":"351-354","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eventrekorder bei kryptogenem Schlaganfall"],"prefix":"10.1007","volume":"27","author":[{"given":"J.","family":"Brachmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Held","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,14]]},"reference":[{"issue":"26","key":"473_CR1","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T et al (2014) Cryptogenic stroke and underlying atrial fibrillation CRYSTAL-AF-trial. N Engl J Med 370(26):2478\u20132486","journal-title":"N Engl J Med"},{"key":"473_CR2","unstructured":"Brachmann et al (2016) Uncovering atrial fibrillation beyond short-term monitoring in cryptogenic stroke patients, three-year results from the cryptogenic stroke and underlying atrial fibrillation trial. Circ Arrhythm Electrophysiol 2016"},{"key":"473_CR3","unstructured":"Swedish Stroke Register, Riksstroke, Medicincentrum, Norrlands universitetssjukhus, 901 85 Ume\u00e5"},{"issue":"26","key":"473_CR4","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"DJ Gladstone","year":"2014","unstructured":"Gladstone DJ et\u00a0al (2014) Atrial fibrillation in patients with cryptogenic stroke (EMBRACE). N Engl J Med 370(26):2467\u20132477","journal-title":"N Engl J Med"},{"issue":"8","key":"473_CR5","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1007\/s00415-013-6935-x","volume":"260","author":"R Wachter","year":"2013","unstructured":"Wachter R et al (2013) Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study. J Neurol 260(8):2042\u20132045","journal-title":"J Neurol"},{"issue":"4","key":"473_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11940-016-0400-y","volume":"18","author":"DJ Miller","year":"2016","unstructured":"Miller DJ et\u00a0al (2016) The evolution and application of cardiac monitoring for occult atrial fibrillation in cryptogenic stroke and TIA. Curr Treat Options Neurol 18(4):17","journal-title":"Curr Treat Options Neurol"},{"issue":"3","key":"473_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1747493016631356","volume":"11","author":"D Toni","year":"2016","unstructured":"Toni D et al (2016) Detection of Silent Atrial Fibrillation aFter Ischemic StrOke (SAFFO) guided by implantable loop recorder: multicentre Italian trial based on stroke unit network with paired cardio-arrhythmology units. Int J Stroke 11(3):361\u2013367","journal-title":"Int J Stroke"},{"issue":"1","key":"473_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr et\u00a0al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35\u201341","journal-title":"Stroke"},{"key":"473_CR9","unstructured":"Leitlinie Diagnostik akuter zerebrovaskul\u00e4rer Erkrankungen, DGN, S1, Sep 2012, verl\u00e4ngert Oct 2015, Deutsche Gesellschaft f\u00fcr Neurologie"},{"key":"473_CR10","unstructured":"Akuttherapie des isch\u00e4mischen Schlaganfalls \u2013 Erg\u00e4nzung 2015 \u2013 Rekanalisierende Therapie \u2013 Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie, Deutsche Gesellschaft f\u00fcr Neurologie"},{"issue":"2","key":"473_CR11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2005.10.044","volume":"47","author":"I Meisner","year":"2006","unstructured":"Meisner I et al (2006) Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 47(2):440\u2013445","journal-title":"J Am Coll Cardiol"},{"key":"473_CR12","doi-asserted-by":"crossref","unstructured":"Carroll JD et\u00a0al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N\u00a0Engl J Med 368(12):1092\u20131100","DOI":"10.1056\/NEJMoa1301440"},{"key":"473_CR13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","volume":"67","author":"DM Kent","year":"2016","unstructured":"Kent DM et\u00a0al (2016) Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J\u00a0Am Coll Cardiol 67:907\u2013917","journal-title":"J Am Coll Cardiol"},{"key":"473_CR14","doi-asserted-by":"crossref","unstructured":"Asberg.S. Stroke. June. 2010. Swedish Stroke Register, Lip GYH, Edwards SJ. Wolff P et\u00a0al. Stroke 1991; 22(8):983\u2013988, Mattle HP, et\u00a0al.","DOI":"10.1161\/01.STR.22.8.983"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-016-0473-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00399-016-0473-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-016-0473-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T09:01:13Z","timestamp":1657702873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00399-016-0473-z"}},"subtitle":["Akzeptierte und m\u00f6gliche Indikationen"],"short-title":[],"issued":{"date-parts":[[2016,11,14]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1007\/s00399-016-0473-z","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,14]]}}}